These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26281472)

  • 1. Payers may cloud pharma's sunny outlook.
    Manag Care; 2015 Jul; 24(7):45. PubMed ID: 26281472
    [No Abstract]   [Full Text] [Related]  

  • 2. Big Pharma's Commedia.
    Steele FR
    Cell; 2005 Dec; 123(6):971-3. PubMed ID: 16360023
    [No Abstract]   [Full Text] [Related]  

  • 3. Big pharma's struggles might benefit health plans.
    Manag Care; 2012 Jan; 21(1):65. PubMed ID: 22334941
    [No Abstract]   [Full Text] [Related]  

  • 4. Balancing Big Pharma's books.
    Jack A
    BMJ; 2008 Feb; 336(7641):418-9. PubMed ID: 18292166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bad medicine. Big Pharma's cash injections lead to poor ethical outcomes.
    Sloane T
    Mod Healthc; 2006 Aug; 36(31):19. PubMed ID: 16958350
    [No Abstract]   [Full Text] [Related]  

  • 6. Wisdom from big pharma's Dr. Gloom. Interview by Abrahm Lustgarten.
    Garnier JP
    Fortune; 2005 Mar; 151(6):38. PubMed ID: 15782880
    [No Abstract]   [Full Text] [Related]  

  • 7. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 2. Pharma's challenges and their commitment to innovation.
    Abou-Gharbia M; Childers WE
    J Med Chem; 2014 Jul; 57(13):5525-53. PubMed ID: 24428137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How will biotechnology fare in pharma's big plan?
    Nat Biotechnol; 1996 Nov; 14(11):1515. PubMed ID: 9634811
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharma's year of trouble and strife.
    Frantz S
    Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
    [No Abstract]   [Full Text] [Related]  

  • 10. Big Pharma's small wonder.
    Fry E
    Fortune; 2014 Jun; 169(8):178-84, 186. PubMed ID: 25211849
    [No Abstract]   [Full Text] [Related]  

  • 11. IT solutions for big Pharma's big headache.
    Krohn R
    J Healthc Inf Manag; 2005; 19(1):13-5. PubMed ID: 15682670
    [No Abstract]   [Full Text] [Related]  

  • 12. Maturing biotechs turn to pharma's markets.
    Ratner M
    Nat Biotechnol; 2005 Mar; 23(3):269. PubMed ID: 15765067
    [No Abstract]   [Full Text] [Related]  

  • 13. Bayer, Novartis, Pfizer Raise Big Pharma's Stake in Gene Therapy.
    Philippidis A
    Hum Gene Ther; 2020 Dec; 31(23-24):1221-1223. PubMed ID: 33337268
    [No Abstract]   [Full Text] [Related]  

  • 14. Payers, consumers benefit as patents expire.
    Manag Care; 2006 Sep; 15(9):72. PubMed ID: 17036942
    [No Abstract]   [Full Text] [Related]  

  • 15. [From orthoclone to denosumab, the fast growing market of monoclonal antibodies].
    Biot J; Fasano C; Dos Santos C
    Med Sci (Paris); 2009 Dec; 25(12):1177-82. PubMed ID: 20035702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Billion-dollar market blossoms as botanicals take root.
    Glaser V
    Nat Biotechnol; 1999 Jan; 17(1):17-8. PubMed ID: 9920256
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug companies should target drug plans, rather than physicians, consultant says.
    Silversides A
    CMAJ; 2010 Jan; 182(1):E21-2. PubMed ID: 19901047
    [No Abstract]   [Full Text] [Related]  

  • 18. Betting on biogenerics.
    Dove A
    Nat Biotechnol; 2001 Feb; 19(2):117-20. PubMed ID: 11175723
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotics: a shot in the arm.
    Leeb M
    Nature; 2004 Oct; 431(7011):892-3. PubMed ID: 15496888
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharma's role is not to bankroll biotech.
    Mackay M
    Nat Biotechnol; 2009 Jun; 27(6):504. PubMed ID: 19513045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.